Categories AlphaGraphs, Earnings, Health Care

CI Earnings: A snapshot of Cigna’s Q2 2023 financial results

Healthcare company The Cigna Group (NYSE: CI) on Thursday reported a 7% increase in revenues for the second quarter of 2023. The company also provided guidance for fiscal 2023.

Cigna Q2 2023 earnings infographic

June quarter revenues increased 7% year-over-year to $48.6 billion. A decrease in net investment income was more than offset by growth in the other business segment.

Shareholders’ net income came in at $1.46 billion or $4.92 per share in the second quarter, compared to $1.56 billion or $4.89 per share in the same period of last year.

We’re pleased with our performance and growth across the breadth of our business in the second quarter as our coworkers continued to drive innovation and deliver effective and affordable solutions supporting the health and vitality of our customers, patients, and clients,” said Cigna’s CEO David Cordani.

Prior Performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top